No Data
No Data
Incyte, Moderna Among Most Shorted S&P 500 Healthcare Stocks in June
Is Incyte Corporation's (NASDAQ:INCY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Incyte (NASDAQ:INCY) has had a great run on the share market with its stock up by a significant 21% over the last three months. Given that the market rewards strong financials in the long-term, we
Goldman Sachs Adjusts Price Target on Incyte to $61 From $60, Maintains Neutral Rating
Incyte (INCY) has an average outperform rating and a price target range of $48 to $88, according to analysts polled by Capital IQ.
Express News | Incyte Corp : JP Morgan Cuts Target Price to $59 From $60
Incyte (INCY) Gains 19.6% in Three Months: Here's Why
Form 144 | Incyte(INCY.US) Officer Proposes to Sell 488.88K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 9, $Incyte(INCY.US)$ Officer BARRY FLANNELLY intends to sell 8,148 shares of its common stock on Jul 9, with a total market value of approximately $488.88K. BARRY
Ivo Stoyanov : ..
raz1 : how do iset my chart to see gaps